Immudyne Inc
BiotechnologyNew York, United States2-10 Employees
Immudyne Inc is a biotechnology company based in New York City, New York. It develops and markets over-the-counter health and wellness products through online channels. The firm has pursued product development, including the Shapiro MD line introduced in 2017. In January 2018, Immudyne announced the appointment of Justin Schreiber as President and Chief Executive Officer. The company operates as a small biotechnology research entity focused on OTC products marketed online.